Table 3.
Entire follow-up period |
|||
---|---|---|---|
PN cases |
Non-PN controls |
p value | |
n = 1387 | n = 2594 | ||
All-cause healthcare costs (PPPM) | |||
Inpatient-admission costs, mean (SD) | $4750 ($9944) | $4002 ($8993) | 0.016 |
Outpatient medical costs, mean (SD) | $8100 ($8,341) | $7408 ($8,007) | 0.010 |
ER costs, mean (SD) | $126 ($620) | $92 ($374) | 0.029 |
Outpatient office-visit costs, mean (SD) | $216 ($302) | $203 ($329) | 0.214 |
Outpatient hospital-based visit costs, mean (SD) | $4906 ($6410) | $4076 ($6280) | <0.001 |
Laboratory-testing costs, mean (SD) | $144 ($309) | $140 ($290) | 0.687 |
Outpatient prescription costs, mean (SD) | $3749 ($3312) | $3681 ($3596) | 0.555 |
Total costs, mean (SD) | $16,600 ($14,450) | $15,090 ($13,399) | 0.001 |
Quarterly healthcare costs (PPPM) | |||
0–90 days postindex, n | 1381 | 2583 | |
Total costs, mean (SD) | $22,777 ($19,074) | $19,460 ($16,064) | <0.001 |
91–180 days postindex, n | 1299 | 2286 | |
Total costs, mean (SD) | $24,402 ($24,760) | $19,235 ($19,769) | <0.001 |
181–270 days postindex, n | 1168 | 1986 | |
Total costs, mean (SD) | $15,766 ($21,032) | $14,052 ($18,286) | 0.008 |
271–360 days postindex, n | 1026 | 1682 | |
Total costs, mean (SD) | $11,955 ($15,774) | $11,518 ($15,756) | 0.404 |
ER, emergency department (room); PN, peripheral neuropathy; PPPM, per patient per month; SD, standard deviation.